An avian influenza vaccine for humans targeting the polymerase B2 protein inside the capsid instead of hemagglutinin or neuramidase on the virus surface
Open Access
- 31 December 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 66 (5) , 975-977
- https://doi.org/10.1016/j.mehy.2005.11.017
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T CellsJournal of Clinical Oncology, 2005
- Characterization of the 1918 influenza virus polymerase genesNature, 2005
- Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional MicroarrayPLoS Medicine, 2005
- Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic miceCellular Immunology, 2005
- Progress and controversies in developing cancer vaccinesJournal of Translational Medicine, 2005
- How to prepare now for a recurrence of the 1918 influenza epidemic: Storing lymphocytes from 1918 survivors to use as antibody factoriesMedical Hypotheses, 2005
- PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in miceVirology, 2004
- Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolatesProceedings of the National Academy of Sciences, 2000
- Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A virusesMicrobiology, 2000
- SYFPEITHI: database for MHC ligands and peptide motifsImmunogenetics, 1999